Resultado de búsqueda
Feng Zhang (China, 1981) es un neurocientífico especializado en optogenética y biología de síntesis, que investiga sobre herramientas de edición del ADN y su aplicación al tratamiento futuro de enfermedades psiquiátricas.
Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the ...
Zhang is a molecular biologist developing and applying novel molecular technologies for studying the brain. Zhang pioneered the development of genome editing tools for use in eukaryotic cells – including human cells – from natural microbial CRISPR-Cas9 systems.
Articles 1–20. HHMI / Massachusetts Institute of Technology / Broad Institute of MIT and Harvard - Cited by 168,985 - neuroscience - microbiology - optogenetics - genome engineering.
20 de nov. de 2023 · Engineering PNMA2 for mRNA delivery. March 4, 2024. Madigan, Zhang, Raghavan et al. characterize the human PNMA2 protein and show it forms capsids that can be engineered for mRNA delivery. Read more in PNAS.
Dr. Zhang is a molecular biologist focused on improving human health. He played an integral role in the development of two revolutionary technologies, optogenetics and CRISPR-Cas systems, including pioneering the use of Cas9 for genome editing and discovering CRISPR-Cas12 and Cas13 systems and developing them for therapeutic and diagnostic ...
Feng Zhang is a neuroscientist and molecular engineer who developed CRISPR tools for genome editing and diagnostics. He is a professor at MIT, a core member of the Broad Institute, and an investigator at the Howard Hughes Medical Institute.
